- Home
- PRE vs HEQ Comparison
PRE vs HEQ Comparison
Compare PRE & HEQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PRE | HEQ |
|---|---|---|
| Founded | 2014 | 2011 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Investment Managers |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 131.3M | 133.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PRE | HEQ |
|---|---|---|
| Price | $15.49 | $10.97 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $32.00 | N/A |
| AVG Volume (30 Days) | ★ 156.8K | 43.1K |
| Earning Date | 11-10-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.78% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $77,079,000.00 | N/A |
| Revenue This Year | $219.28 | N/A |
| Revenue Next Year | $124.38 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 201.54 | N/A |
| 52 Week Low | $3.10 | $9.08 |
| 52 Week High | $18.48 | $11.84 |
Technical Indicators
Market Signals| Indicator | PRE | HEQ |
|---|---|---|
| Relative Strength Index (RSI) | 48.58 | 63.23 |
| Support Level | $15.00 | $10.77 |
| Resistance Level | $16.50 | $10.88 |
| Average True Range (ATR) | 1.06 | 0.10 |
| MACD | -0.15 | 0.02 |
| Stochastic Oscillator | 14.66 | 93.55 |
Price Performance
Historical ComparisonAbout PRE Prenetics Global Limited
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.
About HEQ John Hancock Hedged Equity & Income Fund of Beneficial Interest
John Hancock Hedged Equity & Income Fund is a closed-end management investment company. Its investment objective is to provide total return with a focus on current income and gains and also consisting of long-term capital appreciation. It invests in various sectors such as financials, consumer discretionary, information technology, energy, healthcare, materials, real estate, consumer staples, short-term investments, and others.